Acasti Pharma (ACST) Competitors $3.37 -0.03 (-0.88%) (As of 10/25/2024) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends ACST vs. ADVM, RPTX, CRDL, PLX, PYXS, OTLK, IFRX, VTYX, CNTX, and RANIShould you be buying Acasti Pharma stock or one of its competitors? The main competitors of Acasti Pharma include Adverum Biotechnologies (ADVM), Repare Therapeutics (RPTX), Cardiol Therapeutics (CRDL), Protalix BioTherapeutics (PLX), Pyxis Oncology (PYXS), Outlook Therapeutics (OTLK), InflaRx (IFRX), Ventyx Biosciences (VTYX), Context Therapeutics (CNTX), and Rani Therapeutics (RANI). These companies are all part of the "pharmaceutical products" industry. Acasti Pharma vs. Adverum Biotechnologies Repare Therapeutics Cardiol Therapeutics Protalix BioTherapeutics Pyxis Oncology Outlook Therapeutics InflaRx Ventyx Biosciences Context Therapeutics Rani Therapeutics Adverum Biotechnologies (NASDAQ:ADVM) and Acasti Pharma (NASDAQ:ACST) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, community ranking, dividends, valuation, analyst recommendations, profitability, media sentiment and risk. Does the media refer more to ADVM or ACST? In the previous week, Adverum Biotechnologies had 10 more articles in the media than Acasti Pharma. MarketBeat recorded 11 mentions for Adverum Biotechnologies and 1 mentions for Acasti Pharma. Adverum Biotechnologies' average media sentiment score of 0.64 beat Acasti Pharma's score of -0.71 indicating that Adverum Biotechnologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adverum Biotechnologies 3 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Acasti Pharma 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative Is ADVM or ACST more profitable? Acasti Pharma's return on equity of -13.61% beat Adverum Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets Adverum BiotechnologiesN/A -65.14% -40.52% Acasti Pharma N/A -13.61%-11.56% Do analysts rate ADVM or ACST? Adverum Biotechnologies presently has a consensus price target of $27.83, indicating a potential upside of 357.79%. Acasti Pharma has a consensus price target of $10.00, indicating a potential upside of 196.74%. Given Adverum Biotechnologies' higher possible upside, equities analysts plainly believe Adverum Biotechnologies is more favorable than Acasti Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adverum Biotechnologies 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83Acasti Pharma 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders hold more shares of ADVM or ACST? 48.2% of Adverum Biotechnologies shares are owned by institutional investors. Comparatively, 6.1% of Acasti Pharma shares are owned by institutional investors. 4.2% of Adverum Biotechnologies shares are owned by insiders. Comparatively, 13.5% of Acasti Pharma shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has stronger earnings & valuation, ADVM or ACST? Acasti Pharma has lower revenue, but higher earnings than Adverum Biotechnologies. Acasti Pharma is trading at a lower price-to-earnings ratio than Adverum Biotechnologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdverum Biotechnologies$3.60M35.13-$117.17M-$5.99-1.02Acasti PharmaN/AN/A-$12.85M-$1.44-2.34 Which has more risk and volatility, ADVM or ACST? Adverum Biotechnologies has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500. Comparatively, Acasti Pharma has a beta of 1.52, meaning that its share price is 52% more volatile than the S&P 500. Does the MarketBeat Community believe in ADVM or ACST? Adverum Biotechnologies received 56 more outperform votes than Acasti Pharma when rated by MarketBeat users. However, 70.65% of users gave Acasti Pharma an outperform vote while only 60.39% of users gave Adverum Biotechnologies an outperform vote. CompanyUnderperformOutperformAdverum BiotechnologiesOutperform Votes36960.39% Underperform Votes24239.61% Acasti PharmaOutperform Votes31370.65% Underperform Votes13029.35% SummaryAdverum Biotechnologies and Acasti Pharma tied by winning 8 of the 16 factors compared between the two stocks. Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Get Acasti Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ACST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACST vs. The Competition Export to ExcelMetricAcasti PharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$31.68M$6.45B$5.06B$8.82BDividend YieldN/A8.11%5.18%4.07%P/E Ratio-2.9610.78126.3117.81Price / SalesN/A243.711,178.7474.57Price / CashN/A22.1633.8632.53Price / Book0.515.474.684.68Net Income-$12.85M$153.61M$119.54M$226.08M7 Day PerformanceN/A-2.00%-1.83%-1.04%1 Month Performance5.64%-7.46%-3.60%1.04%1 Year Performance60.48%31.82%31.91%26.28% Acasti Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACSTAcasti Pharma2.3584 of 5 stars$3.37-0.9%$10.00+196.7%+59.0%$31.68MN/A-2.9632ADVMAdverum Biotechnologies4.1779 of 5 stars$6.08-1.5%$27.83+357.8%-32.5%$126.46M$3.60M0.00190Analyst ForecastShort Interest ↓RPTXRepare Therapeutics2.672 of 5 stars$2.88+1.4%$10.00+247.2%-44.7%$122.43M$51.13M0.00180CRDLCardiol Therapeutics2.7497 of 5 stars$1.50-3.8%$8.75+483.3%+81.1%$122.40M$60,000.00-4.0020Analyst ForecastAnalyst RevisionNews CoveragePLXProtalix BioTherapeuticsN/A$1.65-2.2%N/A+22.0%$121.75M$65.49M-13.00200Analyst UpgradePYXSPyxis Oncology1.0178 of 5 stars$2.04-46.6%$10.00+390.2%+165.3%$121.32MN/A-1.9660Analyst ForecastNews CoverageGap DownHigh Trading VolumeOTLKOutlook Therapeutics1.2029 of 5 stars$5.11-3.2%$48.20+843.2%-40.0%$120.90MN/A-0.4920IFRXInflaRx3.0863 of 5 stars$2.03-0.5%$8.00+294.1%+34.2%$119.53M$70,000.000.0060Gap UpVTYXVentyx Biosciences2.4892 of 5 stars$1.68-2.6%$10.00+497.0%-27.1%$118.44MN/A-0.7373CNTXContext Therapeutics2.0835 of 5 stars$1.53-6.1%$6.25+308.5%+81.1%$114.75MN/A-1.797Gap DownRANIRani Therapeutics3.1632 of 5 stars$2.04-0.5%$11.71+474.2%+2.5%$108.96M$2.72M0.00110Analyst Forecast Related Companies and Tools Related Companies ADVM Alternatives RPTX Alternatives CRDL Alternatives PLX Alternatives PYXS Alternatives OTLK Alternatives IFRX Alternatives VTYX Alternatives CNTX Alternatives RANI Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ACST) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acasti Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acasti Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ACST Stock Alerts